Benign Prostate Hypertrophy Drugs

← Back to Class List

PDL Status Values

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.

To request a Prior Authorization, please use this form.

Generic Name Brand Name Form PDL
Status
Current Drug Use Criteria New Drug Evaluation
doxazosin mesylate DOXAZOSIN MESYLATE TABLET Y    
doxazosin mesylate CARDURA TABLET Y    
finasteride PROSCAR TABLET Y    
finasteride FINASTERIDE TABLET Y    
tamsulosin HCl TAMSULOSIN HCL CAPSULE Y    
tamsulosin HCl FLOMAX CAPSULE Y    
terazosin HCl TERAZOSIN HCL CAPSULE Y    
alfuzosin HCl ALFUZOSIN HCL ER TAB ER 24H N PA Document  
doxazosin mesylate CARDURA XL TAB ER 24 N PA Document  
dutasteride DUTASTERIDE CAPSULE N PA Document  
dutasteride AVODART CAPSULE N PA Document  
silodosin RAPAFLO CAPSULE N PA Document  
silodosin SILODOSIN CAPSULE N PA Document  
tadalafil TADALAFIL TABLET N PA Document  
tadalafil CIALIS TABLET N PA Document  
dutasteride/tamsulosin HCl DUTASTERIDE-TAMSULOSIN CPMP 24HR    
dutasteride/tamsulosin HCl JALYN CPMP 24HR